These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1365416)
21. Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen. Morelli M; Fenu S; Carta A; Di Chiara G Behav Brain Res; 1996 Sep; 79(1-2):93-100. PubMed ID: 8883820 [TBL] [Abstract][Full Text] [Related]
22. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons. Van Vliet BJ; Mulder AH; Schoffelmeer AN J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934 [TBL] [Abstract][Full Text] [Related]
23. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase. Makman MH; Dvorkin B Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967 [TBL] [Abstract][Full Text] [Related]
24. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore. Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526 [TBL] [Abstract][Full Text] [Related]
25. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Trampus M; Ferri N; Adami M; Ongini E Eur J Pharmacol; 1993 Apr; 235(1):83-7. PubMed ID: 8100197 [TBL] [Abstract][Full Text] [Related]
26. Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen. Noble F; Cox BM J Neurochem; 1995 Jul; 65(1):125-33. PubMed ID: 7790855 [TBL] [Abstract][Full Text] [Related]
27. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist. Brewster WK; Nichols DE; Riggs RM; Mottola DM; Lovenberg TW; Lewis MH; Mailman RB J Med Chem; 1990 Jun; 33(6):1756-64. PubMed ID: 1971308 [TBL] [Abstract][Full Text] [Related]
28. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex? Isacson R; Kull B; Wahlestedt C; Salmi P Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337 [TBL] [Abstract][Full Text] [Related]
29. Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction. Unterwald EM; Cuntapay M Neuropharmacology; 2000 Jan; 39(3):372-81. PubMed ID: 10698003 [TBL] [Abstract][Full Text] [Related]
30. Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice. Wang T; Nowrangi D; Yu L; Lu T; Tang J; Han B; Ding Y; Fu F; Zhang JH J Neuroinflammation; 2018 Jan; 15(1):2. PubMed ID: 29301581 [TBL] [Abstract][Full Text] [Related]
31. Dopamine receptor multiplicity: "D1-like'-"D2-like' interactions and " D1-like" receptors not linked to adenylate cyclase. Waddington JL; Deveney AM Biochem Soc Trans; 1996 Feb; 24(1):177-82. PubMed ID: 8674655 [No Abstract] [Full Text] [Related]
32. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Meschler JP; Howlett AC Neuropharmacology; 2001 Jun; 40(7):918-26. PubMed ID: 11378162 [TBL] [Abstract][Full Text] [Related]
33. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum. Dong ZJ; Guo X; Chen LJ; Han YF; Jin GZ Life Sci; 1997; 61(4):465-72. PubMed ID: 9244373 [TBL] [Abstract][Full Text] [Related]
34. Effects of somatostatin on dopamine sensitive adenylate cyclase activity in the caudate-putamen of the rat. Moser A; Reavill C; Jenner P; Marsden CD; Cramer H Exp Brain Res; 1986; 62(3):567-71. PubMed ID: 2873048 [TBL] [Abstract][Full Text] [Related]
36. The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease. Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD Psychopharmacology (Berl); 1995 Feb; 117(3):287-97. PubMed ID: 7770604 [TBL] [Abstract][Full Text] [Related]
37. Dopamine and somatostatin modulated adenylate cyclase activity in the rat caudate-putamen following unilateral cortical ablation. Moser A; Reavill C; Liebetrau A; Jenner P; Marsden CD; Cramer H Exp Brain Res; 1987; 68(2):406-10. PubMed ID: 2891560 [TBL] [Abstract][Full Text] [Related]
38. [Effects of A68930 on rhythmical respiratory discharge in isolated neonatal rat brainstem slice]. Jiao YG; Wu M; Wu ZH Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):9-12. PubMed ID: 19218099 [TBL] [Abstract][Full Text] [Related]
40. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]